| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 May 2026 | 7 May 2026 |
| Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve the Audited Financial Results (both Standalone & Consolidated) for the Quarter & Year ended 31st March 2026 and to recommend the equity dividend (if any) for the FY 2025-26. The Board of Directors of the Company in their meeting held on 13.05.2026 i.e. today, has inter-alia considered and approved the Audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter and year ended 31st March, 2026 together with the Auditors Report thereon. The Board has also recommended 10% Equity Dividend (One rupee per share) on Equity Capital of the Company for the Financial Year 2025-26. (As per BSE Announcement dated on: 13.05.2026) | ||
| Board Meeting | 30 Jan 2026 | 23 Jan 2026 |
| Quarterly Results Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve the Un-audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter and Nine Months ended 31st December, 2025. Outcome of the Board meeting dated 30th January, 2026 (As Per BSE Announcement Dated on: 30/01/2026) | ||
| Board Meeting | 31 Oct 2025 | 28 Oct 2025 |
| Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 inter alia to consider and approve the Un-audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter and Half Year ended 30th September 2025. Outcome of Board Meeting dated 31st October, 2025. Un-audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter & Half year ended 30th September, 2025. (As Per BSE Announcement Dated on:31.10.2025) | ||
| Board Meeting | 12 Aug 2025 | 7 Aug 2025 |
| Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve the Un-audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter ended 30th June 2025. Outcome of Board Meeting dated 12th August, 2025 (As per BSE Announcement Dated on 12/08/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.